71 related articles for article (PubMed ID: 29635903)
1. The dialyzable leukocyte extract Transferon
Hernández-Esquivel MA; Pérez-Torres A; Romero-Romero L; Reyes-Matute A; Loaiza B; Mellado-Sánchez G; Pavón L; Medina-Rivero E; Pestell RG; Pérez-Tapia SM; Velasco-Velázquez MA
Biomed Pharmacother; 2018 May; 101():938-944. PubMed ID: 29635903
[TBL] [Abstract][Full Text] [Related]
2. Herpes murine model as a biological assay to test dialyzable leukocyte extracts activity.
Salinas-Jazmín N; Estrada-Parra S; Becerril-García MA; Limón-Flores AY; Vázquez-Leyva S; Medina-Rivero E; Pavón L; Velasco-Velázquez MA; Pérez-Tapia SM
J Immunol Res; 2015; 2015():146305. PubMed ID: 25984538
[TBL] [Abstract][Full Text] [Related]
3. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
[TBL] [Abstract][Full Text] [Related]
4. Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®).
Mellado-Sánchez G; Lázaro-Rodríguez JJ; Avila S; Vallejo-Castillo L; Vázquez-Leyva S; Carballo-Uicab G; Velasco-Velázquez M; Medina-Rivero E; Pavón L; Chacón-Salinas R; Pérez-Tapia SM
J Immunol Res; 2019; 2019():2754920. PubMed ID: 31223627
[TBL] [Abstract][Full Text] [Related]
5. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A
Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873
[TBL] [Abstract][Full Text] [Related]
6. CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®).
Jiménez-Uribe AP; Valencia-Martínez H; Carballo-Uicab G; Vallejo-Castillo L; Medina-Rivero E; Chacón-Salinas R; Pavón L; Velasco-Velázquez MA; Mellado-Sánchez G; Estrada-Parra S; Pérez-Tapia SM
J Immunol Res; 2019; 2019():2198508. PubMed ID: 31093509
[TBL] [Abstract][Full Text] [Related]
7. Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract "Transferon Oral": The Starting Point to Understand Its Mechanism of Action.
Vallejo-Castillo L; Favari L; Vázquez-Leyva S; Mellado-Sánchez G; Macías-Palacios Z; López-Juárez LE; Valencia-Flores L; Medina-Rivero E; Chacón-Salinas R; Pavón L; Pérez-Tapia SM
Front Pharmacol; 2020; 11():569039. PubMed ID: 33117165
[TBL] [Abstract][Full Text] [Related]
8. Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.
Hu M; Peng S; He Y; Qin M; Cong X; Xing Y; Liu M; Yi Z
Oncotarget; 2015 Jun; 6(17):15348-61. PubMed ID: 25915156
[TBL] [Abstract][Full Text] [Related]
9. Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract Intended for Batch Release.
Carballo-Uicab G; Linares-Trejo JE; Mellado-Sánchez G; López-Morales CA; Velasco-Velázquez M; Pavón L; Estrada-Parra S; Pérez-Tapia SM; Medina-Rivero E
Molecules; 2019 Sep; 24(19):. PubMed ID: 31547184
[TBL] [Abstract][Full Text] [Related]
10. Transferon™, a peptide mixture with immunomodulatory properties is not immunogenic when administered with various adjuvants.
Avila S; Muñoz-García L; Vázquez-Leyva S; Salinas-Jazmín N; Medina-Rivero E; Pavón L; Mellado-Sánchez G; Chacón-Salinas R; Estrada-Parra S; Vallejo-Castillo L; Pérez-Tapia SM
J Immunotoxicol; 2017 Dec; 14(1):169-177. PubMed ID: 28707490
[TBL] [Abstract][Full Text] [Related]
11. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
[TBL] [Abstract][Full Text] [Related]
12. Batch-to-batch reproducibility of Transferon™.
Medina-Rivero E; Merchand-Reyes G; Pavón L; Vázquez-Leyva S; Pérez-Sánchez G; Salinas-Jazmín N; Estrada-Parra S; Velasco-Velázquez M; Pérez-Tapia SM
J Pharm Biomed Anal; 2014 Jan; 88():289-94. PubMed ID: 24099727
[TBL] [Abstract][Full Text] [Related]
13. The Effect of a Histone Deacetylase Inhibitor (AR-42) on Canine Prostate Cancer Growth and Metastasis.
Elshafae SM; Kohart NA; Altstadt LA; Dirksen WP; Rosol TJ
Prostate; 2017 May; 77(7):776-793. PubMed ID: 28181686
[TBL] [Abstract][Full Text] [Related]
14. Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells.
Moon DO; Choi YH; Moon SK; Kim WJ; Kim GY
Toxicol In Vitro; 2010 Oct; 24(7):1927-34. PubMed ID: 20696233
[TBL] [Abstract][Full Text] [Related]
15. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation.
Guo Z; Xing Z; Cheng X; Fang Z; Jiang C; Su J; Zhou Z; Xu Z; Holmberg A; Nilsson S; Liu Z
PLoS One; 2015; 10(5):e0124292. PubMed ID: 26010447
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells.
Sigstedt SC; Hooten CJ; Callewaert MC; Jenkins AR; Romero AE; Pullin MJ; Kornienko A; Lowrey TK; Slambrouck SV; Steelant WF
Int J Oncol; 2008 May; 32(5):1085-90. PubMed ID: 18425335
[TBL] [Abstract][Full Text] [Related]
18. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines.
Sicoli D; Jiao X; Ju X; Velasco-Velazquez M; Ertel A; Addya S; Li Z; Andò S; Fatatis A; Paudyal B; Cristofanilli M; Thakur ML; Lisanti MP; Pestell RG
Cancer Res; 2014 Dec; 74(23):7103-14. PubMed ID: 25452256
[TBL] [Abstract][Full Text] [Related]
19. Human antigen R is positively associated with malignant aggressiveness via upregulation of cell proliferation, migration, and vascular endothelial growth factors and cyclooxygenase-2 in prostate cancer.
Mitsunari K; Miyata Y; Asai A; Matsuo T; Shida Y; Hakariya T; Sakai H
Transl Res; 2016 Sep; 175():116-28. PubMed ID: 27140699
[TBL] [Abstract][Full Text] [Related]
20. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
